BLOG

Thursday, November 26, 2020

Laurus Labs gains 7% in two days on acquisition of Richcore Lifesciences

Motilal Oswal Securities maintains 'buy' rating on Laurus Labs with target price of Rs 410 per share

from Home Page https://ift.tt/3mc6Rp2
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...